Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. - Wikidata - wikimedia - TriplyDB

Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate.

Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate.

http://www.wikidata.org/entity/Q34409210

about

Chordin-like 1, a bone morphogenetic protein-4 antagonist, is upregulated by hypoxia in human retinal pericytes and plays a role in regulating angiogenesis The clinical utility of aflibercept for diabetic macular edema The role of aflibercept in the management of diabetic macular edema Alternative Medicine in Diabetes - Role of Angiogenesis, Oxidative Stress, and Chronic Inflammation Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium VEGF localisation in diabetic retinopathy.Pegaptanib sodium for the treatment of neovascular age-related macular degeneration.Treatment of age-related macular degeneration.Emerging pharmacotherapies for diabetic macular edema.Vascular endothelial growth factor level in the serum of diabetic patients with retinopathy.Intravitreal bevacizumab treatment for retinal neovascularization and vitreous hemorrhage in proliferative diabetic retinopathy Role of pegaptanib sodium in the treatment of neovascular age-related macular degeneration Optimal current and future treatments for diabetic macular oedema.Identification of compounds that inhibit IGF-I signaling in hyperglycemia.Visual acuity and foveal thickness after vitrectomy for macular edema associated with branch retinal vein occlusion: a case series.Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in macular edema with central retinal vein occlusion.Vascular endothelial growth factor-B gene transfer exacerbates retinal and choroidal neovascularization and vasopermeability without promoting inflammation.The pathogenesis of edema in diabetic maculopathy.Vitreous inflammatory factors in macular edema with central retinal vein occlusion.Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture.VEGF-A165b is cytoprotective and antiangiogenic in the retina Comparison of three strains of diabetic rats with respect to the rate at which retinopathy and tactile allodynia develop.Characterization of a mouse model of hyperglycemia and retinal neovascularization Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy.Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease.VEGF: From Discovery to Therapy: The Champalimaud Award Lecture.Visual prognosis and vitreous molecules after vitrectomy for macular edema with branch retinal vein occlusion.Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy.The pathogenesis of diabetic retinopathy: old concepts and new questions.Targeting Neovascularization in Ischemic Retinopathy: Recent Advances Abnormal angiogenesis in diabetes mellitus.Early peripheral laser photocoagulation of nonperfused retina improves vision in patients with central retinal vein occlusion (Results of a proof of concept study).Retinal vein occlusion and macular edema - critical evaluation of the clinical value of ranibizumab.Medical treatment of diabetic retinopathy.Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes.Role of vascular permeability factor/vascular endothelial growth factor in eye disease.Current intravitreal pharmacologic therapies for diabetic macular edema.Expression of thrombospondin-1 in ischemia-induced retinal neovascularization Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment

P2860

Q24652148-C171ACFE-E254-45A2-91C9-682F8CFD9593 Q26783575-149C798E-8BDA-430A-87A4-C73C35BF79C8 Q26798348-2E125DD7-0141-4B0D-978B-3954DB1DAC1D Q26801343-00796791-3564-45A6-98DB-74A13A732041 Q28262797-0AE323B0-BEC1-405C-AB76-BF0A0949A24D Q28359761-164F346D-B1E3-4C98-A8F3-1A909CBDB1CA Q32035851-7550F4FF-16AA-40B5-9748-04DB0953F8C6 Q33216197-DB5F1C64-A54B-4949-AEBE-11F8CAC0B0D4 Q33226171-7BB1F063-E999-4D2C-AF07-295C9AA5DBB4 Q33304852-8883F926-30CA-47FA-AFF9-6536230D3212 Q33306345-840731BD-B819-42EA-8548-5BE86D7F9A1B Q33492339-EBCA6ACE-830B-44E4-BE3E-FE37A38572E0 Q33492369-8161503E-8180-49C7-937E-6CE52766CF13 Q33523991-C52F3DC7-29AB-499B-ACB6-BFB1AAAD0AC9 Q33527441-0C7D3E62-9B76-49CE-A201-8361E73F830D Q33568145-4A9E0B57-B50E-40F9-B8E9-EA6794F723D1 Q33806214-370C2D59-4B1A-4E5D-9593-5A7F194878C7 Q33834038-CC6A08FB-738E-4C41-AB74-666C1AA40C8B Q33887327-6CD3A4CA-9DE9-4CDD-AF9C-0E7D697773F1 Q33888116-767EE877-5743-462B-A31C-3AF456647DB6 Q33902419-FC0AB916-E4DD-41BD-8154-5FE4FFCCF87B Q34022623-919D7673-30F0-48BC-8791-E289B357C3C2 Q34081378-E457DA50-5C21-4832-8ECE-07EC74782A79 Q34254645-7A0BB265-4A45-4578-A2B7-0C25789E012A Q34440571-4CC6A905-13C2-43D2-9D19-28E2BE286607 Q34499843-73769334-E262-444D-813C-E6E8A27C2704 Q34518374-47C059BE-A343-44F1-B585-19B630DD954D Q34616286-AC136C71-46A8-4255-ACB7-00747DCAA91A Q34621295-A1B2BABD-17A8-4351-8C20-67F8F64884C4 Q34658478-E79C60BA-6970-44AC-A765-B1E320F59201 Q34972210-36D43AFF-6892-4C82-899A-462772C10FE6 Q35033890-E2E04188-EFFA-4987-8EF5-9E539E3421ED Q35068919-C6E5D944-1C18-49D8-A372-D2AC1712EF63 Q35089799-FC431288-6164-4B84-BFE2-B998A6C472C9 Q35175679-F3098270-B812-47E4-AE18-FDEC474033EC Q35298251-BA543CFA-6639-4D4B-B683-A28AE4A4E20E Q35300661-2CA180D8-44A2-47E1-972D-D4C81693597D Q35650268-5E8B6102-DB0B-45FB-A517-3DCE9B24ED5C Q35745334-83BE665F-CF89-4BA3-8AA5-5BC5AD5E2253 Q35747297-3A248789-1547-4AD9-9E87-25001CBC12ED

P2860

Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate.

http://www.wikidata.org/entity/Q34409210

description

1996 nî lūn-bûn

@nan

1996 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

Intravitreous injections of va ...... ngiopathy in an adult primate.

@ast

Intravitreous injections of va ...... ngiopathy in an adult primate.

@en

Intravitreous injections of va ...... ngiopathy in an adult primate.

@nl

type

label

Intravitreous injections of va ...... ngiopathy in an adult primate.

@ast

Intravitreous injections of va ...... ngiopathy in an adult primate.

@en

Intravitreous injections of va ...... ngiopathy in an adult primate.

@nl

prefLabel

Intravitreous injections of va ...... ngiopathy in an adult primate.

@ast

Intravitreous injections of va ...... ngiopathy in an adult primate.

@en

Intravitreous injections of va ...... ngiopathy in an adult primate.

@nl

P1433

Q34409210-E9EB2731-2C52-4D15-9820-45BB6903F65D

P1476

Q34409210-813E1728-5787-48AA-87A9-54B3AD49D649

P2093

Q34409210-02A2A898-FCD0-419B-AA08-7FDDB836C508

Q34409210-12EC270E-544F-4ECF-9218-35167E0E3CA3

Q34409210-2195A82A-0A31-40E4-B15F-B6D7C60225D9

Q34409210-2810062A-2C88-4D42-BF6E-4D453845BA4E

Q34409210-420A3B83-0A27-4A48-B6BB-BB2933AF8429

Q34409210-4B4A230C-27A9-4A73-9576-8B645E6A597A

Q34409210-850A8BAF-B467-4676-B71B-50241FB2101C

Q34409210-C5947B78-8F9C-4A90-A95B-DEA7EC134FEE

P304

Q34409210-2E463B81-8268-46A9-AE2C-0D73D27A065B

P31

Q34409210-34D15455-2080-4B23-AFA4-8CDA1B394713

P356

Q34409210-1DF8E1CF-1FBF-49C0-B309-2E67723E3BE6

P433

Q34409210-FFEAD214-81FA-4744-AE4B-C61030EF9C85

P478

Q34409210-2278F86C-9FD3-48E4-B661-075EBDB3622B

P577

Q34409210-26040162-B2CE-4BB9-B446-61FD1BE899BF

P698

Q34409210-D67694B4-7908-4132-B827-ED3316ED291E

P921

Q34409210-6B401327-CDFD-4DAF-9D47-55EEFECF76C3

P356

S0161-6420(96)30420-X

P1433

P1476

Intravitreous injections of va ...... ngiopathy in an adult primate.

@en

P2093

Adamis AP

http://www.w3.org/2001/XMLSchema#string

Chatzistefanou K

http://www.w3.org/2001/XMLSchema#string

Ferrara N

http://www.w3.org/2001/XMLSchema#string

Flynn E

http://www.w3.org/2001/XMLSchema#string

Gragoudas ES

http://www.w3.org/2001/XMLSchema#string

Jakobiec FA

http://www.w3.org/2001/XMLSchema#string

Miller JW

http://www.w3.org/2001/XMLSchema#string

Tolentino MJ

http://www.w3.org/2001/XMLSchema#string

P304

1820-1828

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0161-6420(96)30420-X

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

1996-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8942877

http://www.w3.org/2001/XMLSchema#string

P921